CAR T therapies in multiple myeloma: unleashing the future
Cancer Gene Therapy – CAR T therapies in multiple myeloma: unleashing the future
Cancer Gene Therapy – CAR T therapies in multiple myeloma: unleashing the future
Nature Communications – Many low- and middle-income countries, including The Gambia, had low COVID-19 vaccination coverage during the emergence of the Delta and Omicron variants.…
Immunogenomic information displays predictive capability in terms of immunotherapy resistance in metastatic uveal melanoma.
Frontline pembrolizumab plus trastuzumab/chemotherapy improved overall survival in HER2-positive, unresectable or metastatic gastric/GEJ cancer.
Treatment with EVT801 was well tolerated and led to a stable disease rate of 46% in patients with advanced ovarian cancer.
David Y.T. Chen, MD, has been recognized as a 2024 Castle Connolly Top Doctor and named to Castle Connolly’s Top AAPI Doctors list.
In his closing remarks, Yi-Bin Chen, MD, shares his aspirations for the future of graft versus host disease management, emphasizing the need for further clinical…
High-intensity focused ultrasound produced noninferior salvage treatment-free survival vs radical prostatectomy in localized prostate cancer.
Cretostimogene grenadenorepvec elicited durable responses in high-risk BCG-unresponsive non–muscle-invasive bladder cancer with carcinoma in situ.
European Journal of Human Genetics – Overcoming barriers to single-cell RNA sequencing adoption in low- and middle-income countries
Those with metastatic castration-resistant prostate cancer in the BRCA subgroup experienced worse outcomes vs those in non-BRCA subgroups, according to the results of the CAPTURE…